Posted On: 11/22/2013 6:10:55 PM
Post# of 102453
. July 25, 2012 - Val Brickates Kennedy
Tuesday’s biggest gainers and decliners 6:42 p.m. March 1, 2011 - Kate Gibson
Novavax grabs drug-stock spotlight 12:49 p.m. March 1, 2011 - Val Brickates Kennedy
Novavax shares rally on government contract 10:03 a.m. March 1, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 3:38 p.m. July 27, 2010 - MarketWatch
Baxter, Affymetrix lead drug stocks lower 1:05 p.m. April 22, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 3:56 p.m. March 24, 2010 - MarketWatch
Poniard, Genzyme lead drug stocks south 10:10 a.m. March 24, 2010 - Val Brickates Kennedy
Drug stocks turn higher; Shire, XenoPort gain 12:59 p.m. Feb. 19, 2010 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 5:16 p.m. Feb. 8, 2010 - MarketWatch
Drug stocks turn higher; Cell Therapeutics tumbles 1:14 p.m. Feb. 8, 2010 - Val Brickates Kennedy
Novavax shares down 9% 9:37 a.m. Feb. 8, 2010 - Nick Godt
Novavax, Rovi end flu-vaccine-development plan 2:27 a.m. Feb. 8, 2010 - Robert Daniel
Novavax raises $21 million in stock offering 9:10 a.m. Dec. 9, 2009 - Val Brickates Kennedy
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Drug stocks split; Theravance slides on setback 1:22 p.m. Nov. 30, 2009 - Val Brickates Kennedy
Novavax sees Phase III vaccine testing in 2010 9:32 a.m. Nov. 30, 2009 - Val Brickates Kennedy
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch
New Top Stocks to Buy Under $10 with Big Upside 7:16 a.m. Nov. 18, 2013 - 247WallSt.com
Breakthrough In Virus Vaccination Can Instigate A Super Run Of Novavax 12:41 p.m. Nov. 17, 2013 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:11 a.m. Nov. 14, 2013 - benzinga.com
Novavax Shares Edge Higher as the New England Journal of Medicine Has Published Data on Co.'s Bird Flu Vaccine 4:26 p.m. Nov. 13, 2013 - benzinga.com
Novavax Management Discusses Q3 2013 Results - Earnings Call Transcript 7:20 p.m. Nov. 7, 2013 - Seeking Alpha
Two Speculative Biotech Stocks 11:00 a.m. Oct. 31, 2013 - RealMoney.com
Buy Novavax On Vaccine Market Growth 2:31 p.m. Oct. 30, 2013 - Seeking Alpha
First Week Of NVAX December 21st Options Trading 10:54 a.m. Oct. 23, 2013 - TheStreet.com
Wall Street Analysts’ Top Stocks to Buy Trading Under $10 7:35 a.m. Sept. 30, 2013 - 247WallSt.com
John McCamant Scans Under The Radar For Promising Biotechs 9:11 a.m. Sept. 27, 2013 - Seeking Alpha
NVAX: Insiders Vs. Shorts 2:48 p.m. Sept. 26, 2013 - TheStreet.com
First Week Of November 16th Options Trading For Novavax (NVAX) 2:05 p.m. Sept. 26, 2013 - TheStreet.com
Novavax: A Vaccine Company On The Rise 2:31 p.m. Sept. 25, 2013 - Seeking Alpha
Novavax: Why Investors Are Excited Now 12:22 p.m. Sept. 25, 2013 - Seeking Alpha
Novavax, Inc. - Shareholder/Analyst Call 4:10 p.m. Sept. 24, 2013 - Seeking Alpha
Novavax's CEO Hosts Analyst and Investor Update Conference (Transcript) 4:10 p.m. Sept. 24, 2013 - Seeking Alpha
Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA 7:03 a.m. Sept. 24, 2013 - benzinga.com
Novavax Prices Public Offering of Common Stock at $3.14 per Share 7:02 a.m. Sept. 24, 2013 - benzinga.com
3 Stocks Under $5 With Triple-Digit Upside 4:04 p.m. Sept. 20, 2013 - Seeking Alpha
3 Stocks Under $5 With Huge Upside 8:30 a.m. Sept. 20, 2013 - streetauthority.com
Financial Reports, Partnerships, Settlement Agreements, and Strategic Acquisitions - Research Report on Mallinckrodt, WellCare, Mindray, Oxygen Biotherapeutics, and Novavax 8:00 a.m. Nov. 19, 2013 - PR Newswire
New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu 5:01 p.m. Nov. 13, 2013 - GlobeNewswire
Novavax Reports Third-Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - GlobeNewswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013 4:58 p.m. Oct. 30, 2013 - GlobeNewswire
Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc. 3:40 p.m. Oct. 10, 2013 - PR Newswire
Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray 8:00 a.m. Oct. 9, 2013 - PR Newswire
Novavax Initiates Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate 4:35 p.m. Oct. 7, 2013 - GlobeNewswire
Novavax Completes $100 Million Public Offering of Common Stock 11:29 a.m. Sept. 27, 2013 - GlobeNewswire
Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst 8:00 a.m. Sept. 27, 2013 - PR Newswire
Novavax Prices Public Offering of Common Stock 8:06 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA 8:00 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Host an Analyst and Investor Update Call With Webcast 6:25 p.m. Sept. 17, 2013 - GlobeNewswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Novavax Highlights Positive Results From Partner's Clinical Trial of Vaccine Using Matrix-M(TM) 9:03 a.m. Sept. 13, 2013 - GlobeNewswire
Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013 5:00 p.m. Sept. 12, 2013 - PR Newswire
ICAAC Presentations Highlight Potential Protective Effects of Novavax' RSV Vaccine Candidate 8:30 a.m. Sept. 11, 2013 - GlobeNewswire
Technical Scrutiny: Novavax Inc., MannKind Corp., Galena Biopharma Inc., and Ariad Pharma Inc. 2:00 p.m. Sept. 10, 2013 - PR Newswire
$NVAX Company News
Novavax Inc. up 16% in premarket 6:52 a.m. Oct. 25, 2012 - Steve Gelsi
Novavax gains 11% on flu vaccine update 11:29 a.m
Tuesday’s biggest gainers and decliners 6:42 p.m. March 1, 2011 - Kate Gibson
Novavax grabs drug-stock spotlight 12:49 p.m. March 1, 2011 - Val Brickates Kennedy
Novavax shares rally on government contract 10:03 a.m. March 1, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 3:38 p.m. July 27, 2010 - MarketWatch
Baxter, Affymetrix lead drug stocks lower 1:05 p.m. April 22, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 3:56 p.m. March 24, 2010 - MarketWatch
Poniard, Genzyme lead drug stocks south 10:10 a.m. March 24, 2010 - Val Brickates Kennedy
Drug stocks turn higher; Shire, XenoPort gain 12:59 p.m. Feb. 19, 2010 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 5:16 p.m. Feb. 8, 2010 - MarketWatch
Drug stocks turn higher; Cell Therapeutics tumbles 1:14 p.m. Feb. 8, 2010 - Val Brickates Kennedy
Novavax shares down 9% 9:37 a.m. Feb. 8, 2010 - Nick Godt
Novavax, Rovi end flu-vaccine-development plan 2:27 a.m. Feb. 8, 2010 - Robert Daniel
Novavax raises $21 million in stock offering 9:10 a.m. Dec. 9, 2009 - Val Brickates Kennedy
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Drug stocks split; Theravance slides on setback 1:22 p.m. Nov. 30, 2009 - Val Brickates Kennedy
Novavax sees Phase III vaccine testing in 2010 9:32 a.m. Nov. 30, 2009 - Val Brickates Kennedy
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch
New Top Stocks to Buy Under $10 with Big Upside 7:16 a.m. Nov. 18, 2013 - 247WallSt.com
Breakthrough In Virus Vaccination Can Instigate A Super Run Of Novavax 12:41 p.m. Nov. 17, 2013 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:11 a.m. Nov. 14, 2013 - benzinga.com
Novavax Shares Edge Higher as the New England Journal of Medicine Has Published Data on Co.'s Bird Flu Vaccine 4:26 p.m. Nov. 13, 2013 - benzinga.com
Novavax Management Discusses Q3 2013 Results - Earnings Call Transcript 7:20 p.m. Nov. 7, 2013 - Seeking Alpha
Two Speculative Biotech Stocks 11:00 a.m. Oct. 31, 2013 - RealMoney.com
Buy Novavax On Vaccine Market Growth 2:31 p.m. Oct. 30, 2013 - Seeking Alpha
First Week Of NVAX December 21st Options Trading 10:54 a.m. Oct. 23, 2013 - TheStreet.com
Wall Street Analysts’ Top Stocks to Buy Trading Under $10 7:35 a.m. Sept. 30, 2013 - 247WallSt.com
John McCamant Scans Under The Radar For Promising Biotechs 9:11 a.m. Sept. 27, 2013 - Seeking Alpha
NVAX: Insiders Vs. Shorts 2:48 p.m. Sept. 26, 2013 - TheStreet.com
First Week Of November 16th Options Trading For Novavax (NVAX) 2:05 p.m. Sept. 26, 2013 - TheStreet.com
Novavax: A Vaccine Company On The Rise 2:31 p.m. Sept. 25, 2013 - Seeking Alpha
Novavax: Why Investors Are Excited Now 12:22 p.m. Sept. 25, 2013 - Seeking Alpha
Novavax, Inc. - Shareholder/Analyst Call 4:10 p.m. Sept. 24, 2013 - Seeking Alpha
Novavax's CEO Hosts Analyst and Investor Update Conference (Transcript) 4:10 p.m. Sept. 24, 2013 - Seeking Alpha
Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA 7:03 a.m. Sept. 24, 2013 - benzinga.com
Novavax Prices Public Offering of Common Stock at $3.14 per Share 7:02 a.m. Sept. 24, 2013 - benzinga.com
3 Stocks Under $5 With Triple-Digit Upside 4:04 p.m. Sept. 20, 2013 - Seeking Alpha
3 Stocks Under $5 With Huge Upside 8:30 a.m. Sept. 20, 2013 - streetauthority.com
Financial Reports, Partnerships, Settlement Agreements, and Strategic Acquisitions - Research Report on Mallinckrodt, WellCare, Mindray, Oxygen Biotherapeutics, and Novavax 8:00 a.m. Nov. 19, 2013 - PR Newswire
New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu 5:01 p.m. Nov. 13, 2013 - GlobeNewswire
Novavax Reports Third-Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - GlobeNewswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013 4:58 p.m. Oct. 30, 2013 - GlobeNewswire
Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc. 3:40 p.m. Oct. 10, 2013 - PR Newswire
Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray 8:00 a.m. Oct. 9, 2013 - PR Newswire
Novavax Initiates Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate 4:35 p.m. Oct. 7, 2013 - GlobeNewswire
Novavax Completes $100 Million Public Offering of Common Stock 11:29 a.m. Sept. 27, 2013 - GlobeNewswire
Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst 8:00 a.m. Sept. 27, 2013 - PR Newswire
Novavax Prices Public Offering of Common Stock 8:06 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA 8:00 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Host an Analyst and Investor Update Call With Webcast 6:25 p.m. Sept. 17, 2013 - GlobeNewswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Novavax Highlights Positive Results From Partner's Clinical Trial of Vaccine Using Matrix-M(TM) 9:03 a.m. Sept. 13, 2013 - GlobeNewswire
Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013 5:00 p.m. Sept. 12, 2013 - PR Newswire
ICAAC Presentations Highlight Potential Protective Effects of Novavax' RSV Vaccine Candidate 8:30 a.m. Sept. 11, 2013 - GlobeNewswire
Technical Scrutiny: Novavax Inc., MannKind Corp., Galena Biopharma Inc., and Ariad Pharma Inc. 2:00 p.m. Sept. 10, 2013 - PR Newswire
$NVAX Company News
Novavax Inc. up 16% in premarket 6:52 a.m. Oct. 25, 2012 - Steve Gelsi
Novavax gains 11% on flu vaccine update 11:29 a.m
(0)
(0)Scroll down for more posts ▼
